within Pharmacolibrary.Drugs.ATC.J;

model J01GB09
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0013333333333333333,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01GB09</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dibekacin is an aminoglycoside antibiotic structurally related to kanamycin, primarily used to treat severe infections caused by Gram-negative bacteria, particularly Pseudomonas aeruginosa. Its usage has been limited or discontinued in many countries and is generally not considered a first-line therapy today due to the availability of other aminoglycosides and concerns about toxicity.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for dibekacin in adult patients, based on analogy with other aminoglycosides (such as amikacin and kanamycin) due to lack of published specific data.</p><h4>References</h4><ol><li><p>Autret, E, et al., &amp; Laugier, J (1984). Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes. <i>Developmental pharmacology and therapeutics</i> 7 Suppl 1 121–124. DOI:<a href=\"https://doi.org/10.1159/000457240\">10.1159/000457240</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6518951/\">https://pubmed.ncbi.nlm.nih.gov/6518951</a></p></li><li><p>Komiya, I, et al., &amp; Fujita, M (1981). Pharmacokinetics of dibekacin in rabbits and dogs. <i>Journal of pharmacobio-dynamics</i> 4(5) 362–373. DOI:<a href=\"https://doi.org/10.1248/bpb1978.4.362\">10.1248/bpb1978.4.362</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7288554/\">https://pubmed.ncbi.nlm.nih.gov/7288554</a></p></li><li><p>Komiya, I, et al., &amp; Fujita, M (1981). Acute toxicity and pharmacokinetics of dibekacin mice. <i>Journal of pharmacobio-dynamics</i> 4(5) 356–361. DOI:<a href=\"https://doi.org/10.1248/bpb1978.4.356\">10.1248/bpb1978.4.356</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7288553/\">https://pubmed.ncbi.nlm.nih.gov/7288553</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01GB09;
